Literature DB >> 15010258

Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts.

Shanshan Wang1, Zhengui Zheng, Yinqi Weng, Yijun Yu, Daifu Zhang, Weihu Fan, Ruihong Dai, Zhibi Hu.   

Abstract

The aqueous extracts of 24 herbs traditionally used as curing ischemic heart disease in clinic in China were screened for their in vitro angiogenic activity, another twenty-four traditionally used as anti-tumor or anti-inflammatory remedies in China were screened for their in vitro anti-angiogenic activity. The activity of angiogenesis was determined by quantitation of vessels on chick embryo chorioallantoic membrane (CAM) model and cell proliferation of cultured bovine aortic endothelial cells (BAECs). Among the herbal extracts examined, the aqueous extracts of Epimedium sagittatum, Trichosanthes kirilowii and Dalbergia odorifera showed the strong angiogenetic activity both in CAM and BAECs models; and the aqueous extracts of Berberis paraspecta, Catharanthus roseus, Coptis chinensis, Taxus chinensis, Scutellaria baicalensis, Polygonum cuspidatum and Scrophularia ningpoensis elicited significant inhibition at a concentration of 1g dry herb /ml.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15010258     DOI: 10.1016/j.lfs.2003.03.005

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  36 in total

1.  Engineering vascularized tissues using natural and synthetic small molecules.

Authors:  Lauren S Sefcik; Caren E Petrie Aronin; Edward A Botchwey
Journal:  Organogenesis       Date:  2008-10       Impact factor: 2.500

2.  Study on the networks of "Nature-Family-Component" of Chinese medicinal herbs based on association rules mining.

Authors:  Xian-jun Fu; Zhen-guo Wang; Yi Qu; Peng Wang; Yang Zhou; Hua-yun Yu
Journal:  Chin J Integr Med       Date:  2013-08-24       Impact factor: 1.978

3.  Application of Fourier transform near-infrared spectroscopy combined with high-performance liquid chromatography in rapid and simultaneous determination of essential components in crude Radix Scrophulariae.

Authors:  Xiaomeng Li; Dansi Fang; Xiaodong Cong; Gang Cao; Hao Cai; Baochang Cai
Journal:  AAPS PharmSciTech       Date:  2012-10-16       Impact factor: 3.246

4.  A survey on herbal management of hepatocellular carcinoma.

Authors:  Nabil Mohie Abdel-Hamid; Maiiada Hasan Nazmy; Ahmed Wahid Mahmoud; Michael Atef Fawzy; Marco Youssof
Journal:  World J Hepatol       Date:  2011-07-27

5.  Antitumor and anti-angiogenic potentials of isolated crude saponins and various fractions of Rumex hastatus D. Don.

Authors:  Sajjad Ahmad; Farhat Ullah; Muhammad Ayaz; Anwar Zeb; Farman Ullah; Abdul Sadiq
Journal:  Biol Res       Date:  2016-03-12       Impact factor: 5.612

6.  Effect of Fufang Xueshuantong Capsule on a rat model of retinal vein occlusion.

Authors:  Yuan-Zhi Yuan; Fei Yuan; Qin-Yue Xu; Jia Yu; Lei Li; Ju-Li Zhang
Journal:  Chin J Integr Med       Date:  2011-04-21       Impact factor: 1.978

7.  Multifaceted effects of astragaloside IV on promotion of random pattern skin flap survival in rats.

Authors:  Renjin Lin; Huanwen Chen; Daniel Callow; Shihen Li; Lei Wang; Shi Li; Long Chen; Jian Ding; Weiyang Gao; Huazi Xu; Jianzhong Kong; Kailiang Zhou
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

8.  Investigation of the Mechanism of Traditional Chinese Medicines in Angiogenesis through Network Pharmacology and Data Mining.

Authors:  Wingyan Yun; Wenchao Dan; Jinlei Liu; Xinyuan Guo; Min Li; Qingyong He
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-28       Impact factor: 2.629

9.  Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae.

Authors:  Shao Li; Bo Zhang; Duo Jiang; Yingying Wei; Ningbo Zhang
Journal:  BMC Bioinformatics       Date:  2010-12-14       Impact factor: 3.169

10.  Vitexicarpin acts as a novel angiogenesis inhibitor and its target network.

Authors:  Bo Zhang; Lu Liu; Shiwen Zhao; Xu Wang; Liyang Liu; Shao Li
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.